SCHEMBL4402

SCHEMBL4402

Cc1noc(-c2ccc(Br)cc2)c1C1C[C@H]1C(=O)N(C)CCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 2/20 0.36
GAA P10253 1/20 0.36
ACKR3 P25106 9/20 0.36
NPC1 O15118 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LPAR1 Q92633 1/20 0.34
HTR5A P47898 1/20 0.34
GPR88 Q9GZN0 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4131 0.86 LPAR1 (0.46) L3MBTL1RAB9ATSHRGAAACKR3
SCHEMBL4132 0.86 LPAR1 (0.46) L3MBTL1RAB9ATSHRGAAACKR3
SCHEMBL4401 0.80 LPAR1 (0.39) L3MBTL1RAB9ALMNASMN1; SMN2LPAR1
SCHEMBL4393 0.79 NR4A2 (0.40) LPAR1
SCHEMBL18176069 0.77 TRPV1 (0.40) RAB9ASMN1; SMN2GAANPC1
SCHEMBL5839 0.76 LPAR1 (0.48) L3MBTL1RAB9ALMNASMN1; SMN2TSHR
SCHEMBL3926 0.74 ALDH1A1 (0.42) LMNASMN1; SMN2TSHR
SCHEMBL1604 0.71 L3MBTL1 (0.37) L3MBTL1RAB9ALMNASMN1; SMN2TSHR
SCHEMBL6770 0.71 RAB9A (0.42) L3MBTL1RAB9ALMNASMN1; SMN2TSHR
SCHEMBL1743 0.71 L3MBTL1 (0.41) L3MBTL1RAB9ALMNASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed